LANSING, Mich. — Neogen Corporation (NEOG) has received Performance TestedSM Method Certification from the AOAC Research Institute for its Reveal® Q+ for Deoxynivalenol (DON) test, which is designed for the rapid quantification of the mold toxin in grains. The AOAC approval (No. 071901) follows the earlier verification of the test’s performance by the USDA’s Federal Grain Inspection Service (FGIS). […]
Khosla Ventures leads Series A investment in human tissue engineering company Prellis, backing Prellis’ mission to create viable human tissue and organs for research and transplant IMAGE: PRELLIS STRUCTURE TRANSPLANTED ALONE IS SURROUNDED BY SINGLE CELL WALLED CAPILLARIES WITHIN TWO WEEKS OF TRANSPLANTATION INTO IMMUNOCOMPETENT MOUSE (LEFT). HUMAN TUMOR CELLS TRANSPLANTED IN PRELLIS STRUCTURES GROW RAPIDLY, […]
Genome Canada, Ontario Institute for Cancer Research and Thermo Fisher Scientific to focus on pancreatic, prostate and breast cancer CARLSBAD, Calif. — Genome Canada, the Ontario Institute for Cancer Research (OICR) and Thermo Fisher Scientific are collaborating to develop a complete solution of targeted next generation sequencing (NGS) assays and analysis software designed to more effectively assess – […]
SEATTLE and ROCHESTER, Minn. — NanoString Technologies and Mayo Clinic Laboratories have announced a collaboration to develop clinical tests using NanoString’snew GeoMx Digital Spatial Profiler. GeoMx combines spatial and molecular profiling technologies by generating a whole tissue image at single cell resolution while also providing digital profiling data for tens to thousands of RNA or protein analytes for up to 16–20 tissue […]
Khosla Ventures leads Series A investment in human tissue engineering company Prellis, backing Prellis’ mission to create viable human tissue and organs for research and transplant San Francisco, CA–Prellis Biologics today announced that Khosla Ventures has led an $8.7 million Series A investment in the company. The announcement comes as Prellis has reached major tissue engineering […]
— Oligonucleotides up to 300 Bases with Exceptionally Low Error Rate – — Longest Commercial Oligonucleotide Offering Available Today — SAN FRANCISCO–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of its long oligonucleotides, or oligos, product line. At […]
IONTAS announces new antibody optimisation agreement with Teva Pharmaceuticals Cambridge, UK: IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, today announced an agreement with Teva Pharmaceuticals (Teva) to apply its technologies and know-how to the optimisation of human antibodies for use as biotherapeutics. Under the terms of the agreement, […]
We have new CytoSense deployed in dutch waters! This week, as part of dutch monitoring program “Marker Wadden” one of our instruments was deployed in a buoy at Markermeer. The “Marker Wadden” monitoring program has been established in order to (i) map changes in water quality in the Markermeer; (ii) to provide insights into ecosystem […]
— Agreement Enables Twist to Securely Store DNA With Digital Data Encoded — SAN FRANCISCO–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has entered into an agreement with Imagene SA, where Imagene will provide Twist with an encapsulation service […]
Clear Labs chooses IDT’s NGS oligo products for use in groundbreaking NGS-based food safety platform CORALVILLE, IA – As part of its ongoing mission to break down the barriers in genomics research, Integrated DNA Technologies (IDT) is extending its network of collaborations into food quality and safety. Through a new multi-year supplier agreement, IDT will be the […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
